2025-12-31 - Analysis Report
Okay, here's a comprehensive analysis of ARKX based on the data you provided, structured for clarity.

**1) Return Rate Comparison & Analysis**

*   **Ticker:** ARKX (ARK Space Exploration & Innovation ETF)
*   **Company Overview:** An ETF focused on companies involved in space exploration and innovation.
*   **ARKX Cumulative Return:** 44.33%
*   **VOO (S&P 500) Cumulative Return:** 52.05%
*   **Divergence:**
    *   Current Divergence: -7.1% (ARKX is underperforming VOO by 7.1%)
    *   Divergence Range: Max: 10.2%, Min: -35.2%
    *   Relative Divergence: 61.9% (ARKX's current divergence is in the upper-middle range of its historical divergence, closer to its maximum than its minimum).

**Alpha, Beta Analysis Interpretation:**

The table presents rolling 3-year data, providing insights into ARKX's risk-adjusted performance relative to a benchmark (presumably the S&P 500).

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2021-2023  | -7.0% | 80.5% | -10.0% | 0.1 | 0.0 |
| 2022-2024  | 22.0% | 80.5% | 2.0% | 0.0 | 0.0 |
| 2023-2025  | 63.0% | 80.5% | -4.0% | -0.0 | 0.0 |

*   **CAGR (Compound Annual Growth Rate):**  Reflects the average annual return over the period. Fluctuates significantly showing recent volatility (2023-2025 at 63% demonstrates strong recent performance).
*   **MDD (Maximum Drawdown):**  Shows the largest peak-to-trough decline during the period.  A consistent 80.5% MDD is very high, indicating substantial risk and volatility in the ETF.
*   **Alpha:** Measures the fund's performance *above* the benchmark, adjusted for risk.  Negative Alpha in 2021-2023 and 2023-2025 implies underperformance relative to the benchmark. Positive Alpha in 2022-2024 shows outperformance in that period.
*   **Beta:**  Measures the fund's volatility relative to the benchmark. A Beta close to 0 suggests it is not highly correlated with the market (S&P 500), which is expected for a niche ETF like ARKX.
*   **Cap(B):** Unclear what this metric refers to without more context.

**In short:** The CAGR is improving significantly in most recent time frame, 2023-2025. The MDD is very high. Alpha is inconsistent. Beta is negligibly connected to S\&P500.

**2) Recent Stock Price Fluctuations**

*   **Current Close Price:** 29.19
*   **Last Market Data:**
    *   Price: 29.19
    *   Previous Close: 29.30
    *   Change: -0.38 (-1.3%)
*   **Simple Moving Averages (SMA):**
    *   5-day SMA: 29.636
    *   20-day SMA: 28.775
    *   60-day SMA: 29.2132

**Analysis:** The price closed lower than yesterday. The price is below the 5-day and 60-day SMA, but above the 20-day SMA. This *could* suggest a short-term downward trend but that a medium term reversal might be happening.  A drop of -1.3% isn't a huge fluctuation in itself, but combined with the SMA picture, warrants attention.

**3) Technical Indicators & Expected Return**

*   **Market Risk Indicator (MRI):** 0.9 (High Investment Recommended)
*   **RSI (Relative Strength Index):** 53.80 (Neutral â€“ neither overbought nor oversold)
*   **PPO (Percentage Price Oscillator):** 0.42 (Positive, but relatively low, suggesting some bullish momentum)
*   **Hybrid Signal:** cash_0%_Buy 90% of cash (1 shares - Safe - MRI:0.80)
*   **Recent (20 days) relative divergence change:** 7.5 (+) (Short-term increase)
*   **Expected Return (%):** -9.6% (Negative expected return compared to the S&P 500 over 2+ years)
*   **Note on Price Change:**  The small price change of -0.38 suggests that there isn't a *major* fluctuation event occurring, at least not based on this data point alone.

**Analysis:**

*   The MRI suggests the market environment is conducive to investment.
*   The RSI is neutral, not providing a strong buy or sell signal.
*   The PPO is positive, but relatively low suggesting there is little bullish momentum.
*   The "Hybrid Signal" is a recommendation to buy into the stock.
*   The negative expected return is a major red flag, indicating analysts forecast long-term underperformance.

**4) Recent News & Significant Events:**

*   **[2025-11-20] ARK Space Exploration & Innovation ETF (ARKX) - The Motley Fool:** (Likely provides an overview or analysis of the ETF).
*   **[2025-12-29] EXCLUSIVE: UFO Vs. ARKX Space ETF Battle Reveals 'Only Pure Play' Bet on Sector - Benzinga:** Suggests competition or a debate on the best way to invest in the space sector.
*   **[2025-12-24] Trading Systems Reacting to (ARKX) Volatility - Stock Traders Daily:** Reinforces the idea that ARKX is experiencing volatility.
*   **[2025-10-03] Space Exploration ETF (ARKX) Hits New 52-Week High - Nasdaq:** Indicates positive momentum earlier in the period.
*   **[2025-10-16] ARKX: Investing In Space, The Final Frontier (BATS:ARKX) - Seeking Alpha:** Likely a deeper dive into the investment thesis.
*   **[2025-12-24] Invest in Tomorrow's Space Economy With These ETFs - Zacks Investment Research:** Potentially compares ARKX with other space-related ETFs.

**Analysis of News:** The news headlines paint a mixed picture. We see some positive points (52-week high earlier in the period), but also significant emphasis on volatility and competition, as well as coverage of trading systems reacting to that volatility.

**4-2) Analyst Opinions**

*   Analyst Consensus: (No data provided. This would be crucial for a complete analysis.)

**5) Comprehensive Analysis Summary**

Based on the provided data, here's a summary of ARKX:

*   **Performance:** ARKX has underperformed the S&P 500 recently and has a negative expected return compared to the S&P 500 over 2+ years. The historical CAGR fluctuates a lot.
*   **Risk:**  The MDD is high, indicating significant potential for losses. The ETF experiences higher volatility.
*   **Technicals:**  Current price action is slightly bearish in the short term, PPO is negligibly bullish.
*   **News:** News is mixed, highlighting volatility and competition.
*   **Overall:** The information doesn't suggest a strong buy case. The negative expected return, high volatility, and underperformance relative to the S&P 500 are major concerns. The high MRI might be misleading and should be interpreted with caution. The recent news headlines do not paint a positive picture.

**Important Considerations (Missing Data):**

*   **Analyst Consensus:**  Crucially important. We need to know what analysts think about the future prospects of ARKX. What are their price targets and ratings?
*   **Expense Ratio:**  What is the expense ratio of the ETF? A high expense ratio eats into returns.
*   **Holdings:**  What specific companies are held in the ETF?  Understanding the underlying holdings is vital.
*   **Benchmark:** What is the true Benchmark of the ETF? If the correlation between VOO and the ETF is low, we may need to compare the ARKX ETF to a more specific competitor ETF.

Without this missing data, the analysis is incomplete, but based on what *is* available, caution is advised.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.